포토페레시스 제품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Photopheresis Products Market size is expected to reach USD 614.70 Million in 2034 from USD 376.43 Million (2025) growing at a CAGR of 5.6% during 2026-2034.

The global photopheresis products market is gaining momentum due to the increasing prevalence of immune-related disorders and the growing adoption of advanced therapeutic procedures. Photopheresis is widely used in treating conditions such as graft-versus-host disease and certain autoimmune diseases. The rising awareness about these therapies and the growing need for effective treatment options are driving market growth. Additionally, advancements in medical technologies are enhancing the efficiency and accessibility of photopheresis procedures.

Growth drivers include increasing healthcare investments and expanding research in immunotherapy. The rising number of organ transplants worldwide has significantly increased the demand for photopheresis treatments. Technological advancements in devices and treatment protocols are improving patient outcomes and reducing treatment time. Moreover, favorable reimbursement policies in developed regions are encouraging adoption, while growing healthcare infrastructure in emerging economies is expanding market reach.

In the coming years, the photopheresis products market is expected to witness significant growth due to ongoing innovations and increasing clinical applications. Research in personalized medicine and immunotherapy is likely to expand the scope of photopheresis treatments. The integration of advanced technologies and automation in treatment systems will enhance efficiency and accessibility. Emerging markets are expected to offer lucrative opportunities as awareness and healthcare investments continue to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Open System
• Closed System

By Application

• Graft Versus Host Disease
• Cutaneous T-Cell Lymphoma
• Transplant Rejections
• Autoimmune Diseases

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Care
• Others

COMPANIES PROFILED

• Fresenius Kabi AG, Macopharma, Mallinckrodt, PIT Medical Systems, Terumo Corporation, Therakos, Inc a Johnson Johnson company, Haemonetics Corporation, Miltenyi Biotec, Cerus Corporation, Asahi Kasei Medical Co, Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHOTOPHERESIS PRODUCTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Open System Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Closed System Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHOTOPHERESIS PRODUCTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Graft Versus Host Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cutaneous T-Cell Lymphoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Transplant Rejections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Autoimmune Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHOTOPHERESIS PRODUCTS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHOTOPHERESIS PRODUCTS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PHOTOPHERESIS PRODUCTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Fresenius Kabi AG
  • 9.2.2 Macopharma
  • 9.2.3 Mallinckrodt
  • 9.2.4 PIT Medical Systems
  • 9.2.5 Terumo Corporation
  • 9.2.6 Therakos, Inc. (a Johnson & Johnson Company)
  • 9.2.7 Haemonetics Corporation
  • 9.2.8 Miltenyi Biotec
  • 9.2.9 Cerus Corporation
  • 9.2.10 Asahi Kasei Medical Co.Ltd